Clinical Trials

Phase 2/3 Active not recruiting

Carcinoma, Hepatocellular

NCT05902533 2025-12-18

REDEL

33 enrolled

Phase 2/3 Active not recruiting

Anus Neoplasms

NCT04068103 2025-05-07

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

635 enrolled 9 charts

Colonic Neoplasms

NCT05288777 2025-04-18

Breast53

Phase 2/3 Recruiting

45 enrolled

Phase 2/3 Active not recruiting

Breast Neoplasms

NCT02945566 2025-03-27

STAR-TREC

380 enrolled

Rectal Neoplasms

NCT06037980 2025-02-17

PURITY

Phase 2/3 Recruiting

300 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT01404156 2024-08-28

POWERRANGER

29 enrolled

Phase 2/3 Not yet recruiting

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms

NCT06268327 2024-02-20

Adding Adjuvant Cisplatin and Gemicitabine Versus Capecitabine in Triple-negative Breast Cancer Patients in Non pCR After Neoadjuvant Standard Chemotherapy

30 enrolled

Breast Neoplasms

NCT03607656 2023-12-18

CHANGE

270 enrolled

Stomach Neoplasms

NCT04803539 2023-02-21

Artemis

Phase 2/3 Recruiting

260 enrolled

Breast Neoplasms

NCT01962246 2022-02-21

A-C

169 enrolled

Gastroesophageal Junction Adenocarcinoma

NCT05002686 2021-08-24

Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis

60 enrolled

Stomach Neoplasms

NCT03093870 2021-08-03

TreeTopp

151 enrolled 18 charts

Bile Duct Neoplasms, Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms

NCT03158610 2021-05-03

Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer

Phase 2/3 Terminated

20 enrolled

Colorectal Neoplasms

NCT03959150 2021-04-30

Metronomic Chemotherapy With Capecitabine for Pancreatic Cancer

231 enrolled

Pancreatic Neoplasms

NCT00397761 2021-02-17

Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer

Phase 2/3 Withdrawn

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00212615 2020-11-06

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

116 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT01516944 2020-02-13

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

749 enrolled

Stomach Neoplasms

NCT00647530 2019-05-17

FOxTROT

1,053 enrolled

Colonic Neoplasms, Colorectal Neoplasms

NCT03577392 2019-04-04

EXECC

120 enrolled

Quality of Life

NCT00418028 2019-02-22

Standard Versus Continuous Capecitabine in Advanced Breast Cancer

195 enrolled 15 charts

Breast Neoplasms

NCT03423849 2018-02-06

The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy

200 enrolled

Breast Neoplasms

NCT00684216 2017-09-14

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

Phase 2/3 Terminated

10 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT02893540 2016-09-16

Metronomic Versus Conventional Chemotherapy in as Maintenance Treatment in mCRC

250 enrolled

Colorectal Neoplasms

NCT01204437 2016-02-10

ICE-II

400 enrolled

Breast Neoplasms

NCT02529774 2015-08-20

Alternating Systemic and Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer

432 enrolled

Resected Liver Metastases From Colorectal Cancer

NCT01065870 2014-01-29

Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III)

64 enrolled

Pancreatic Neoplasms

NCT00509561 2012-12-18

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

259 enrolled

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01662128 2012-08-10

Efficacy and Safety Of Xeloda as Sequential Adjuvant Therapy After Chemotherapy in Breast Cancer

600 enrolled

Breast Neoplasms

NCT01064999 2012-03-14

A Trial of High Intensity Versus Low Intensity Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

240 enrolled

Rectal Neoplasms

NCT00960284 2012-01-13

PACT-7

102 enrolled

Pancreatic Neoplasms

NCT01415336 2011-08-11

AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer

300 enrolled

Breast Neoplasms

NCT00561522 2010-07-21

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

290 enrolled

Carcinoma, Hepatocellular, Neoplasm Metastasis, Recurrence

NCT00201435 2008-05-20

Weekly Taxol Plus Xeloda® vs Taxotere q3wk Plus Xeloda® in the Treatment of Metastatic BC

224 enrolled